News

14 Mar 2024 CBD API manufactured by CB21 Pharma now complies with CBD Ph.Eur. monograph

CB21 Pharma, a leading manufacturer of cannabis-based active ingredients, is proud to announce its compliance with the new CBD monograph of the European Pharmacopoeia (Ph.Eur.), Supplement 11.5, effective January 2024. This development ensures CB21 Pharma's commitment to meeting the highest standards in CBD production.
27 Nov 2023 CBDepot – the reliable source of synthesized Cannabidiol

As we witness a new round of legal hostilities by Italian and Portuguese authorities against using isolated Cannabidiol, CBDepot can still offer synthesized Cannabidiol for applications and jurisdictions that ban the use of natural, isolated CBD.
17 Jul 2023 Premium, top-level compliant CBD food supplemnts

Are you looking for CBD food supplements with top-level compliance? Look no further!
11 Nov 2022 CBDepot the pioneering EU-GMP supplier of cannabinoid APIs

CBDepot is a pioneer in the production of high-quality cannabinoid ingredients. The company, with roots dating to 2014, has been a leader in helping to establish legal and quality standards for cannabinoid ingredients and the formulation of cannabidiol derivatives that have a fast-growing presence in sectors including food, cosmetics, pharmaceuticals, and other health products.
07 Sep 2022 In autumn 2022, CBDepot returns to live pharma shows

The Pharmacy Show in Birmingham, UK starts October 16th; our stand number is B02 The biggest global pharmaceutical show CPHI is held in Frankfurt starting November 1st; our stand nr. is 110F46.
24 Feb 2022 All CBDepot’s Novel Food applications are now declared valid by both European Commission and the UK’s Food Safety Agency (FSA)

On February 15th, 2022, the European Commission (EC) declared CBDepot’s Novel Food application NF 2021/2283 for isolated trans-Cannabidiol as valid. This sets the number of CBDepot’s valid Novel Food applications with EC and FSA to four.
25 Oct 2021 CBDepot launches the sale of synthesized pharma-grade CBD

CBDepot group starts the marketing of synthesized pharma-grade CBD produced under the EU GMP umbrella of its sister company CB21 Pharma, s.r.o.
13 Jul 2021 CBDepot progresses in certification of its ingredients for use in organic and natural cosmetics

CBDepot’s Cannabidiol (CBD) and Cannabigerol (CBG) natural isolates, Cannabis Sativa Leaf Extract, CBD and CBG types, are now certified cosmetic raw materials under the COSMOS-standard.
03 Jun 2021 CBDepot takes the first step towards marketing authorization of CBG in foods

CBDepot has filed a pre-submission with the European Food Safety Authority (EFSA) for Cannabigerol (CBG), the non-psychoactive cannabinoid compound of hemp, as a novel food ingredient.
04 May 2021 CBDepot achieves COSMOS APPROVED certification for its isolates

Cannabidiol (CBD) and Cannabigerol (CBG) natural isolates, delivered by CBDepot, are now COSMOS APPROVED cosmetic raw materials by IONC GmbH certifier under the COSMOS-standard.
19 Apr 2021 CBDepot and 4MP Cannabidiol Novel Food applications with the UK Food Standards Agency are declared validated and verified Food Supplements

CBDepot s.r.o., with Cannabis Pharma s.r.o. and 4MP Technologies Limited as co-applicants, are delighted to announce that their Regulated Products applications RP70 and RP85 have been validated and verified by the UK Food Standards Agency & Food Standards Scotland. Twelve Secondary Food Supplementary Products linked to the primary dossiers may remain on the UK market for legal sale whilst undergoing the final Risk Assessment period.
25 Mar 2021 Compliant CBD suppositories registered with the Czech State Institute for Drug Control

The certification process of the world's first registered OTC products, the vaginal and rectal CBD suppositories by CB21 Pharma, is completed.
18 Jan 2021 Compliant CBD suppositories hit the market

CBDepot’s sister company CB21 Pharma is launching vaginal and rectal CBD suppositories for over-the-counter (OTC) sales in Europe in the upcoming days.
23 Jun 2020 CBDepot group announces new EU GMP compliant manufacturing site for Cannabidiol APIs

On June 22nd 2020 the Czech National Competent Authority State Institute for Drug Control issued a CERTIFICATE OF GMP COMPLIANCE OF A MANUFACTURER to CB21 Pharma s.r.o, the sister company of CBDepot. Certificate number sukls336513/2019 covers the manufacture of Cannabidiol Active substance and will be visible in the EudraGMDP system within a few days’ time.
18 Jun 2020 Czech Ministry of Health grants export authorization for full spectrum cannabis extract.

PharmaCan s.r.o., the founding JV partner in CBDepot, receives his first export authorization for full spectrum Cannabis extract from the Ministry of Health of the Czech Republic to Spain.
12 May 2020 Novel Food: We still need to do a lot of research on the toxicity of phyto-cannabinoids

An conversation with Boris Baňas from CBDepot about the purpose and requirements of a novel food application
01 Apr 2020 No Fool’s Day Joke - EC validates CBDepot’s Novel Food Application!

On March 27th, the European commission validated CBDepot's application for authorization of pure synthesized form of Cannabidiol as novel food ingredient.
28 Nov 2019 CBDepot files application on trans-Cannabidiol manufactured by chemical synthesis as a novel food

EFSA announced on November 27, 2019, that CBDepot's application on trans-Cannabidiol, synthesized as a novel food ingredient has been registered in the Register of Questions with the reference EFSA-Q-2019-00750.
27 Feb 2019 Upmarket Cannabinoid Solutions by CBDepot

Since January 2019 CBDepot changed its headline yet again to Upmarket Cannabinoid Solutions.
30 Nov 2017 Kosher Certificate

As of September 2017 our CBD and CBG are Kosher certified
18 Sep 2017 CPhI Frankfurt 2017

CPhI is the world’s leading pharmaceutical show.
12 Sep 2017 Canabinoid Conference 2017

CBDepot proudly sponsors the bi-annual Cannabinoid conference
25 Jul 2017 Update on Safety and Side Effects of Cannabidiol

A Review of Clinical Data and Relevant Animal Studies by Kerstin Iffland and Franjo Grotenhermen
25 May 2017 14th International Conference of the European Industrial Hemp Association (EIHA), sponsored by CBDepot

10 reasons to join the “14th International Conference of the European Industrial Hemp Association (EIHA)” Cologne (Germany), 7. – 8. June 2017
04 Apr 2017 Cannabis extracts and pharma-grade cannabinoids: several legal perspectives

A comprehensive guide to regulations on cannabis, cannabis extracts and CBD in the EU.
23 Jan 2017 EIHA CBD Position Paper - update January 2017

This is an updated version (January 2017) of the position paper of the European Industrial Hemp Association (EIHA) on reasonable regulation of cannabidiol (CBD) in food, cosmetics, as herbal natural medicine and as medicinal product, first published in October 2016.
12 Jan 2017 Save the date: MAP-EXPO

MAP-EXPO: Global marketplace for Medicinal & Aromatic Plants / 29.-30.3.2017 / Beursgebouw, Eindhoven
27 Oct 2016 EIHA CBD Position Paper

Position paper of the European Industrial Hemp Association (EIHA) on reasonable regulation of cannabidiol (CBD) in food, cosmetics, as herbal natural medicine and as medicinal product.
25 Oct 2016 Safety and Side Effects of Cannabidiol

Safety and Side Effects of Cannabidiol – A review of clinical data and relevant animal studies by Kerstin If and and Dr. med. Franjo Grotenhermen, nova-Institut (http://www.nova-institut.eu) The study was commissioned by the European Industrial Hemp Association (http://www.eiha.org)
08 Oct 2016 Cannabis Sativa Fraction (Extract THC free)

Exciting new product in our offer!
27 Jun 2016 The expert from Slovakia to co-decide on the future of hemp

Boris Baňas is a successful trader with hemp foods and a leading expert on industrial hemp processing and use in Slovakia. He became a member of the board of the European Industrial Hemp Association (EIHA) at the beginning of June. We asked him what his appointment to the position of this prominent institution might bring to the sector.
23 Jun 2016 Cannabis, extracts of cannabis, cannabidiol: several legal perspectives

This is the newest presentation of Boris Banas - the new board member of the European Industrial Hemp Association (eiha.org)
10 Jun 2016 EIHA.org Press release - The World’s Greatest Conference ever about Industrial Hemp – New president

300 participants from 42 countries met last week in Wesseling near to Cologne, Germany for the latest data and developments, discussions, strategies and networking in the Hemp industry. Can industrial hemp reach 100,000 ha in Europe by 2030?
25 May 2016 We Say YES to cannabis as medicine!

Medical Cannabis Declaration (MCD) charity - a global information campaign on medical cannabis
29 Feb 2016 EIHA.org Press release - Boost for European hemp cultivation

A new press release by EIHA.org has been just released.
CBDepot.eu is the bronze sponsor of the 13th International Conference of the European Industrial Hemp Association - the largest conference on industrial hemp worldwide. Register here.
03 Feb 2016 Hemp Seed Oil vs. Hemp Oil vs. Cannabis Oil vs. CBD oil vs. Cannabidiol

There is and will ever be only one oil related to hemp. The hemp seed oil. All the other „oils“ are technically extracts of Cannabis. With one exception of hemp essential oil which is a vapor fragrance distillate.
21 Dec 2015 PF 2016

Merry Christmas and Happy New Year 2016 to all our friends, partners and supporters!
24 Nov 2015 Press Release: Weed Will Help You

Absolutely legally and without a prescription!
11 Nov 2015 Legal Status of Cannabinoids in end-user products on EU market

A presentation (with comments) by Boris Baňas of Hemp Seed Oil Europe ltd. and CBDepot.eu about the legal status of cannabinoids in end-user products on the EU market.

About us

Contact us - Contact

Contact us for more info & pricing